Antimicrobial Resistance (AMR) Value, Affordability, and… Proposals for a Novel UK Antimicrobial Subscription Model: The Investor Perspective Read more
Health Care Systems Policy, Organisation and… Economic Evaluation Reimagining Prevention for a Healthier, More Prosperous Society Read more
Health Technology Assessment… Israel NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making? Read more
Cell and Gene Therapies Value, Affordability, and… Gene therapies Are Recommendations for HTA of Gene Therapies Being Achieved? Read more
Chronic Diseases Value, Affordability, and… Dermatology The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society Read more
Dementia Economics of Innovation Alzheimer's Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment Read more
Antimicrobial Resistance (AMR) Economics of Innovation A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance Read more
Health Technology Assessment… Value, Affordability, and… Pricing and Reimbursement Real-World Evidence: Current Best Practice for Reimbursement Decision-Making Read more